Novavax outlines $400M 2026 revenue framework while targeting cash runway into 2029
What it means
- What to watch: Earnings calls often reveal more than numbers — focus on tone, cost control, and the next quarter's outlook, as those can signal more than the headline.
- How the stock is trading: $NVAX -9.48% in the latest session.
- Timing: It landed during trading hours — the market got to read it live, so the session move beside it may already carry the reaction.
Where the stock stands
$NVAX last traded at $9.64, -9.48% on the session. That puts it 28% shy of its 52-week high of $13.39 and 55% clear of its low of $6.20 — around the middle of the range. Over the year it has ranged 116% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $NVAX page.
How much coverage it is getting
Nothing else on $NVAX in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
Earnings matter less than how they stack up against expectations — and guidance often tells the real story, even if the numbers look good. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$NVAX earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
The $NVAX page has the full chart, filings, and valuation model. Compare outlets to see if the story is confirmed or just repeated. Wook AI can help track how far $NVAX has come and how this week's coverage stacks up.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $NVAX. It carried $400 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 5, 2026. $NVAX has moved +0.52% ($9.59 to $9.64). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.